Rogco LP’s Novo Nordisk NVO Stock Holding History

Rogco LP’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-25	Closed	-$1.73K	–	205
2025 Q2	$1.73K	Hold	25	–	–	﹤0.01%	195
2025 Q1	$1.74K	Hold	25	–	–	﹤0.01%	205
2024 Q4	$2.15K	Buy	+25	New	+$2.7K	﹤0.01%	210

Other funds holding NVO

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Rogco LP's NVO Position: Q3 2025 in Review

Rogco LP sold out of Novo Nordisk (NVO) in Q3 2025, closing a stake of 25 shares — an estimated $1.73K sold.

Rogco LP first reported a position in NVO in Q4 2024 and held it in 3 quarters. The position peaked at $2.15K in Q4 2024. 1,395 funds tracked by Wall St. Rank hold NVO as of Q3 2025.

Rogco LP reported no remaining Novo Nordisk position as of Q3 2025 after selling out during the quarter.
Rogco LP sold 25 Novo Nordisk shares in Q3 2025, an estimated $1.73K.
Rogco LP first reported a position in Novo Nordisk in Q4 2024 and held it in 3 quarters.
Rogco LP's Novo Nordisk position peaked at $2.15K in Q4 2024.
1,395 funds tracked by Wall St. Rank held Novo Nordisk as of Q3 2025.

Based on Rogco LP's 13F filing for Q3 2025, filed 30 Oct 2025.